HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: Molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells

被引:71
作者
Mingari, MC
Ponte, M
Cantoni, C
Vitale, C
Schiavetti, F
Bertone, S
Bellomo, R
Cappai, AT
Biassoni, R
机构
[1] UNIV GENOA, IST PATOL GEN, I-16132 GENOA, ITALY
[2] IST SCI STUDIO & CURA TUMORI, I-16132 GENOA, ITALY
关键词
cytolytic T lymphocytes; HLA class I molecules; inhibitory receptors; NK cells;
D O I
10.1093/intimm/9.4.485
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A subset of cytolytic T lymphocytes has been shown to express receptors of the NK type (NKR) which can inhibit T cell cytotoxicity induced via the TCR-CD3 pathway. In this study, by the analysis of full length cDNA amplified from representative T cell clones, we show that NKR belonging either to the Ig superfamily, including p58.1, p58.2, p70 and p140, or to the C-type lectin superfamily (CD94/NKG2A), display sequences which are identical to those of the corresponding NKR expressed by CD3(-) NK cells. Moreover, a fragment of cDNA encoding the NKG2A protein was consistently amplified from all CD94(+) T cell clones analyzed. Since different NKR types can be expressed by T cells, we analyzed whether individual T cells could co-express more than one NKR. Analysis of either resting or activated (and cultured) T cell populations revealed that two or more NKR can be co-expressed by single T cells. Moreover, by the analysis of T cell clones, we show that co-expressed receptors are functional and can inhibit independently the TCR-induced cytolytic function. Finally, we investigated whether NKR+ T lymphocytes were also present in lymphoid tissues. No such cells were found in thymus or cord blood, thus further supporting the notion that they represent memory T cells. On the other hand, they were present in all the peripheral tissues analyzed including spleen, lymph nodes and tonsils.
引用
收藏
页码:485 / 491
页数:7
相关论文
共 32 条
[1]  
ARAMBURU J, 1991, J IMMUNOL, V147, P714
[2]  
ARAMBURU J, 1990, J IMMUNOL, V144, P3238
[3]   The human leukocyte antigen (HLA)-C-specific ''activatory'' or ''inhibitory'' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions [J].
Biassoni, R ;
Cantoni, C ;
Falco, M ;
Verdiani, S ;
Bottino, C ;
Vitale, M ;
Conte, R ;
Poggi, A ;
Moretta, A ;
Moretta, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :645-650
[4]   The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules [J].
Carretero, M ;
Cantoni, C ;
Bellon, T ;
Bottino, C ;
Biassoni, R ;
Rodriguez, A ;
PerezVillar, JJ ;
Moretta, L ;
Moretta, A ;
LopezBotet, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (02) :563-567
[5]   MOLECULAR CHARACTERIZATION OF HUMAN CD94 - A TYPE-II MEMBRANE GLYCOPROTEIN RELATED TO THE C-TYPE LECTIN SUPERFAMILY [J].
CHANG, CW ;
RODRIGUEZ, A ;
CARRETERO, M ;
LOPEZBOTET, M ;
PHILLIPS, JH ;
LANIER, LL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) :2433-2437
[6]   INVOLVEMENT OF HLA CLASS-I ALLELES IN NATURAL-KILLER (NK) CELL-SPECIFIC FUNCTIONS - EXPRESSION OF HLA-CW3 CONFERS SELECTIVE PROTECTION FROM LYSIS BY ALLOREACTIVE NK CLONES DISPLAYING A DEFINED SPECIFICITY (SPECIFICITY-2) [J].
CICCONE, E ;
PENDE, D ;
VIALE, O ;
THAN, A ;
DIDONATO, C ;
ORENGO, AM ;
BIASSONI, R ;
VERDIANI, S ;
AMOROSO, A ;
MORETTA, A ;
MORETTA, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :963-971
[7]  
DANDREA A, 1995, J IMMUNOL, V155, P2306
[8]   T-CELL CLONES EXPRESSING THE NATURAL-KILLER CELL-RELATED P58 RECEPTOR MOLECULE DISPLAY HETEROGENEITY IN PHENOTYPIC PROPERTIES AND P58 FUNCTION [J].
FERRINI, S ;
CAMBIAGGI, A ;
MEAZZA, R ;
SFORZINI, S ;
MARCIANO, S ;
MINGARI, MC ;
MORETTA, L .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) :2294-2298
[9]   DNA-SEQUENCE ANALYSIS OF NKG2, A FAMILY OF RELATED CDNA CLONES ENCODING TYPE-II INTEGRAL MEMBRANE-PROTEINS ON HUMAN NATURAL-KILLER-CELLS [J].
HOUCHINS, JP ;
YABE, T ;
MCSHERRY, C ;
BACH, FH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :1017-1020
[10]  
Lazetic S, 1996, J IMMUNOL, V157, P4741